A detailed history of Spire Wealth Management transactions in Shockwave Medical, Inc. stock. As of the latest transaction made, Spire Wealth Management holds 405 shares of SWAV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
405
Previous 555 27.03%
Holding current value
$0
Previous $105,000 24.76%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$191.17 - $325.63 $28,675 - $48,844
-150 Reduced 27.03%
405 $131,000
Q4 2023

Feb 06, 2024

SELL
$160.99 - $215.69 $338,079 - $452,949
-2,100 Reduced 79.1%
555 $105,000
Q3 2023

Nov 08, 2023

BUY
$194.33 - $283.97 $19,433 - $28,397
100 Added 3.91%
2,655 $528,000
Q2 2023

Aug 09, 2023

SELL
$223.05 - $302.68 $20,520 - $27,846
-92 Reduced 3.48%
2,555 $729,000
Q1 2023

May 09, 2023

BUY
$175.41 - $217.92 $160,500 - $199,396
915 Added 52.83%
2,647 $573,000
Q4 2022

Feb 03, 2023

SELL
$204.38 - $296.82 $216,847 - $314,926
-1,061 Reduced 37.99%
1,732 $356,000
Q3 2022

Nov 07, 2022

SELL
$195.21 - $310.53 $150,311 - $239,108
-770 Reduced 21.61%
2,793 $777,000
Q2 2022

Jul 22, 2022

BUY
$115.91 - $214.48 $55,520 - $102,735
479 Added 15.53%
3,563 $681,000
Q1 2022

Apr 18, 2022

SELL
$127.96 - $207.36 $131,414 - $212,958
-1,027 Reduced 24.98%
3,084 $639,000
Q4 2021

Jan 14, 2022

BUY
$165.13 - $241.83 $169,588 - $248,359
1,027 Added 33.3%
4,111 $733,000
Q2 2021

Jul 26, 2021

SELL
$131.45 - $201.49 $134,999 - $206,930
-1,027 Reduced 24.98%
3,084 $585,000
Q1 2021

May 21, 2021

BUY
$92.73 - $142.05 $381,213 - $583,967
4,111 New
4,111 $509,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.